WILSON CHARLES 4
4 · Unum Therapeutics Inc. · Filed Apr 11, 2019
Insider Transaction Report
Form 4
WILSON CHARLES
DirectorChief Executive Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-03-01+174,400→ 174,400 totalExercise: $4.36Exp: 2029-03-01→ Common Stock (174,400 underlying)
Footnotes (1)
- [F1]25% of the shares vests on March 1, 2020, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Persons continuous service with the Issuer.